[6-K] – Legend Biotech Corp (LEGN) (CIK 0001801198)

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Analyzing...

10/14/2025 - 12:00 AM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Legend Biotech Corp

NASDAQ:LEGN

LEGN Rankings

#1244 Ranked by Market Cap

N/A Ranked by Dividends

LEGN Latest News

Aug 26, 2025

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Aug 18, 2025

Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Aug 11, 2025

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

Jul 28, 2025

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

Jun 3, 2025

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

LEGN Latest SEC Filings

Oct 14, 2025

[6-K] – Legend Biotech Corp (LEGN) (CIK 0001801198)

Oct 7, 2025

[6-K] Legend Biotech Corp Current Report (Foreign Issuer)

Sep 26, 2025

[144] Legend Biotech Corp SEC Filing

Sep 24, 2025

[144] Legend Biotech Corp SEC Filing

Sep 23, 2025

[144] Legend Biotech Corp SEC Filing

LEGN Stock Data

Market Cap 6.06B

Float 182.17M

Insiders Ownership 1.3%

Institutions Ownership 47.49%

Short Percent 4.26%

Industry Biotechnology

Sector Healthcare

Website Link

Country United States

City Somerset